Learn

Rheumatoid arthritis is a relatively common inflammatory arthritis and is self-reported by 2% of the Australian population.

This module summarises the literature on contemporary understanding of adult rheumatoid arthritis (RA) focusing on current therapy, especially biological therapy.

This MJA narrative review shares more.

Learning Outcomes

1. List the eight approved biological disease-modifying antirheumatic drugs (bDMARDs), also in combination therapy with traditional DMARDs
2. Recognise the potential of those therapeutic options with a realistic goal of remission, guiding patients in the process to lead a ‘normal life’
3. Identify the ‘window opportunity’ that changes the long-term phenotype of the disease.

Details

Authors: Graeme Jones, Peter Nas, Stephen Hall

Article Type: Narrative review